COVID-19 mRNA Vaccines Boost Cancer Patient Survival 5-Fold
Scientists just discovered something extraordinary about COVID-19 vaccines and cancer survival rates. Researchers at MD Anderson Cancer Center found that cancer patients who received Pfizer or Moderna mRNA vaccines within 100 days of starting immunotherapy lived substantially longer than unvaccinated patients. Lung cancer patients saw their three-year survival rates nearly double, while melanoma patients experienced…
